Effectiveness and Safety of Fasudil Hydrochloride in the Treatment of Cerebral Vasospasm after Subarachnoid Hemorrhage in China:a Systematic Review
Ren Lin
Abstract
Ren Lin
Abstract
OBJECTIVE:To evaluate the effectiveness and safety of fasudil hydrochloride in the treatment of cerebral vasospasm(CVS) after subarachnoid hemorrhage(SAH).METHODS:Random controlled trails(RCT) on fasudil hydrochloride treatment for CVS after SAH were gathered from CBM,CNKI,Wanfang database,VIP.Other relative researches were searched manually.Methodological quality of included researches was evaluated,and meta-analysis was carried out by RevMan5.0 software.RESULTS:A total of 19 RCT were collected.Results of Meta-analysis showed that for the total effective rate and the incidence of cerebral vasospasm,there was no significant differences between fasudil 30 mg,q 8 h and nimodipine 24 mg·d-1.RR and 95%CI were equal to 1.06(0.98,1.16) and 1.17(0.53,2.59).The differences of the total effective rate between trail group and nimodipine 10 mg·d-1 had statistical significance,and the RR and 95%CI were 1.30(1.11,1.52).CONCLUSION:According to the current evidence in China,the treatment of fasudil for CVS after SAH can increase the total effective rate and reduce the incidence of cerebral vasospasm.The difference of effectiveness between fasudil and nimodipine is affected by dose and route of administration.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE:To evaluate the effectiveness and safety of fasudil hydrochloride in the treatment of cerebral vasospasm(CVS) after subarachnoid hemorrhage(SAH).METHODS:Random controlled trails(RCT) on fasudil hydrochloride treatment for CVS after SAH were gathered from CBM,CNKI,Wanfang database,VIP.Other relative researches were searched manually.Methodological quality of included researches was evaluated,and meta-analysis was carried out by RevMan5.0 software.RESULTS:A total of 19 RCT were collected.Results of Meta-analysis showed that for the total effective rate and the incidence of cerebral vasospasm,there was no significant differences between fasudil 30 mg,q 8 h and nimodipine 24 mg·d-1.RR and 95%CI were equal to 1.06(0.98,1.16) and 1.17(0.53,2.59).The differences of the total effective rate between trail group and nimodipine 10 mg·d-1 had statistical significance,and the RR and 95%CI were 1.30(1.11,1.52).CONCLUSION:According to the current evidence in China,the treatment of fasudil for CVS after SAH can increase the total effective rate and reduce the incidence of cerebral vasospasm.The difference of effectiveness between fasudil and nimodipine is affected by dose and route of administration.
Key concepts: Nimodipine, Fasudil, Medicine, Cerebral vasospasm, Subarachnoid hemorrhage, Anesthesia, Vasospasm, Randomized controlled trial